Variations in human NCF1, including copy number variations and SNPs, result in impaired immunity, as the enzyme is unable to function as an NADPH oxidase to trigger the oxidative burst in phagocytes, inducing autoimmune diseases such as arthritis, autoimmune lung disease, and lupus erythematosus. This evidence concerns the gene FMO5 and autoimmune disease.